Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
35.90
-1.92 (-5.08%)
Mar 31, 2025, 9:45 AM EDT - Market open
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$95.93
Upside
+167.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $104 → $117 | Buy | Maintains | $104 → $117 | +225.91% | Mar 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $115 | Buy | Maintains | $140 → $115 | +220.33% | Mar 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +228.69% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +164.62% | Feb 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 → $136 | Strong Buy | Maintains | $121 → $136 | +278.83% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +164.62% | Feb 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +228.69% | Jan 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +289.97% | Jan 13, 2025 |
| Wedbush | Wedbush | Hold Reiterates $46 → $48 | Hold | Reiterates | $46 → $48 | +33.70% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +164.62% | Dec 24, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $88 | Buy | Maintains | $75 → $88 | +145.13% | Dec 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $105 → $102 | Buy | Maintains | $105 → $102 | +184.12% | Nov 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 | Strong Buy | Maintains | $121 | +237.05% | Nov 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $109 → $121 | Strong Buy | Maintains | $109 → $121 | +237.05% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +114.48% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +223.12% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.